| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/2010 | US20100035940 Cyclin Dependent Kinase Inhibitors |
| 02/11/2010 | US20100035939 Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes |
| 02/11/2010 | US20100035938 Cooling Compounds |
| 02/11/2010 | US20100035937 Solubilized non-steroidal anti-inflammatory drugs |
| 02/11/2010 | US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
| 02/11/2010 | US20100035935 Anthranilamide compounds, process for their production and pesticides containing them |
| 02/11/2010 | US20100035934 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators |
| 02/11/2010 | US20100035933 Kits, Recloseable Containers, Blanks And Methods Of Treatment |
| 02/11/2010 | US20100035932 Novel formyl peptide receptor like 1 agonists that induce macrophage tumor necrosis factor alpha and computational structure-activity relationship analysis of thereof |
| 02/11/2010 | US20100035931 Tripyridyl carboxamide orexin receptor antagonists |
| 02/11/2010 | US20100035930 UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 02/11/2010 | US20100035929 Unnatural dispyrin analogues, preparation and uses thereof |
| 02/11/2010 | US20100035928 Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate |
| 02/11/2010 | US20100035927 Medicament for prophylactic and/or therapeutic treatment of alzheimer-type dementia |
| 02/11/2010 | US20100035926 Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 02/11/2010 | US20100035925 Compounds, pharmaceutical compositions an dmethods for inhibiting hiv infectivity |
| 02/11/2010 | US20100035924 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 02/11/2010 | US20100035923 Vr1 vanilloid receptor antagonists with a iononic substructure |
| 02/11/2010 | US20100035922 Quinuclidine carbonate salts and medicinal composition thereof |
| 02/11/2010 | US20100035921 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 02/11/2010 | US20100035920 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE |
| 02/11/2010 | US20100035919 Compounds useful as inhibitors of protein kinases |
| 02/11/2010 | US20100035918 Imidazolone Compounds and Methods of Making and Using the Same |
| 02/11/2010 | US20100035917 Pyrrolo[2,3-b]pyridin-4-yl-benzenesulfonamide compounds as 1kk2 inhibitors |
| 02/11/2010 | US20100035916 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 02/11/2010 | US20100035915 Indolizine derivatives and the use thereof as antidiabetics |
| 02/11/2010 | US20100035914 Azabicyclic compounds as inhibitors of monoamines reuptake |
| 02/11/2010 | US20100035913 Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiestrase (PDE) 4 inhibitors |
| 02/11/2010 | US20100035912 Small Molecule Inhibitors of Retroviral Assembly and Maturation |
| 02/11/2010 | US20100035911 Drug combinations to treat hyperproliferative disorders |
| 02/11/2010 | US20100035910 Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts |
| 02/11/2010 | US20100035909 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
| 02/11/2010 | US20100035908 Substituted acetophenones useful as pde4 inhibitors |
| 02/11/2010 | US20100035907 New 2,4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 02/11/2010 | US20100035906 Dipyridyl-dihydropyrazolones and their use |
| 02/11/2010 | US20100035904 Phenobarbital salts; methods of making; and methods of use thereof |
| 02/11/2010 | US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases |
| 02/11/2010 | US20100035902 5-aryl-substituted dihydropyridopyrimidines and dihydropyridazines and use thereof as mineral corticoid antagonists |
| 02/11/2010 | US20100035901 Adenine derivative as inhibitors of hsp90 for the treatment of cancer |
| 02/11/2010 | US20100035900 6-Arylmethyl-substituted pyrazolopyrimidines |
| 02/11/2010 | US20100035899 5,7-DISUBSTITUTED[1.3]THIAZOLO[4,5-d]PYRIMIDIN-2(3H)-AMINE DERIVATIVES AND THEIR USE IN THERAPY |
| 02/11/2010 | US20100035898 Organic compounds |
| 02/11/2010 | US20100035897 Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists |
| 02/11/2010 | US20100035896 Combination of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent |
| 02/11/2010 | US20100035895 2-aminocarbonyl-pyridine derivatives |
| 02/11/2010 | US20100035894 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 02/11/2010 | US20100035893 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/11/2010 | US20100035892 Method for assembling high-purity chemical libraries, compounds suppressing acetyl coenzyme a carboxylase activities discovered by same |
| 02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
| 02/11/2010 | US20100035890 Use of ranolazine for the treatment of cardiovascular diseases |
| 02/11/2010 | US20100035889 Use of PDE III Inhibitors For The Treatment of Asymptomatic (Occult) Heart Failure |
| 02/11/2010 | US20100035888 Diaryl Urea for Treating Pulmonary Hypertension |
| 02/11/2010 | US20100035887 Therapeutic compounds for blocking dna synthesis of pox viruses |
| 02/11/2010 | US20100035886 Parenteral formulations of dopamine agonists |
| 02/11/2010 | US20100035885 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 02/11/2010 | US20100035884 Kinase inhibitor |
| 02/11/2010 | US20100035883 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 02/11/2010 | US20100035882 Inhibition of pde2a |
| 02/11/2010 | US20100035880 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 02/11/2010 | US20100035879 N-sulfonylcarboximidamide apoptosis promoters |
| 02/11/2010 | US20100035878 Inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation |
| 02/11/2010 | US20100035877 Methods and compositions for treating pathologies associated with bdnf signaling |
| 02/11/2010 | US20100035876 Use of a Kinase Inhibitor for the Treatment of Particular Resistant Tumors |
| 02/11/2010 | US20100035875 Triazolopyridine jak inhibitor compounds and methods |
| 02/11/2010 | US20100035874 Organic compounds |
| 02/11/2010 | US20100035873 Diaryl Compounds and Uses Thereof |
| 02/11/2010 | US20100035872 Pde10 inhibitors and related compositions and methods |
| 02/11/2010 | US20100035871 Benzoxazine derivatives and uses thereof |
| 02/11/2010 | US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds |
| 02/11/2010 | US20100035869 Targeted nitroxide agents |
| 02/11/2010 | US20100035868 Methods of treatment of uterine pathological conditions |
| 02/11/2010 | US20100035867 Inhibitors of Cyclic Nucleotide Synthesis and Their Use for Therapy of Various Diseases |
| 02/11/2010 | US20100035866 Novel substituted-1, 1-dioxo-benzo[1,2,4]thiadiazin-3ones, preparation method thereof, and pharmaceutical composition containing the same |
| 02/11/2010 | US20100035865 Sulfonamides and Pharmaceutical Compositions Thereof |
| 02/11/2010 | US20100035864 2,2-Dimethyl-4-oxo-4-(4-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-[1,4]diazepan-1-yl)-butyric acid, hydrochloride; obesity, type II diabetes mellitus and metabolic syndrome |
| 02/11/2010 | US20100035863 2 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions |
| 02/11/2010 | US20100035862 Novel aza-cyclic indole-2-carboxamides and methods of use thereof |
| 02/11/2010 | US20100035861 Meptazinol Biligand Derivatives and/or their Salts, Preparation Method and Uses Thereof |
| 02/11/2010 | US20100035860 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 02/11/2010 | US20100035859 Treatment of protein aggregation diseases |
| 02/11/2010 | US20100035858 Novel Compositions and Methods for Binding and Inhibiting 5-HT4 Receptor |
| 02/11/2010 | US20100035857 N-[3-(4-{(2S,3R)-2-(-(4-{[(2S, 5S, 3R, 4R, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)perhydro-2H-pyran-2-yl]ethyl-2-yl}phenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phenyl)propyl]-N-methylmethanesulfonamide; anticholesterol agent; low density lipoprotein; treating atherosclerosis |
| 02/11/2010 | US20100035856 Beta-LACTAM-CONTAINING FORMULATIONS WITH INCREASED STABILITY IN AQUEOUS SOLUTION |
| 02/11/2010 | US20100035855 Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject |
| 02/11/2010 | US20100035854 Dry powder formulations |
| 02/11/2010 | US20100035853 Method for preventing or treating cisplatin-induced nephrotoxicity |
| 02/11/2010 | US20100035852 Compositions and methods for treating inflammatory conditions of the bowel |
| 02/11/2010 | US20100035851 Agent for improving insulin resistance |
| 02/11/2010 | US20100035850 Method of treatment for inflammatory bowel disease |
| 02/11/2010 | US20100035849 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 02/11/2010 | US20100035848 Therapy for disorders of the proximal digestive tract |
| 02/11/2010 | US20100035847 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/11/2010 | US20100035846 Method for the treatment of acne and certain dosage forms thereof |
| 02/11/2010 | US20100035845 Tigecycline formulations |
| 02/11/2010 | US20100035843 Methods for attenuating allergen-induced airway hyperreactivity using cd1d dependent antagonists |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100035841 Inhibitors of tyrosine kinases and uses thereof |
| 02/11/2010 | US20100035839 Merocyanine derivatives |
| 02/11/2010 | US20100035838 Cross-linked polysaccharide gels |
| 02/11/2010 | US20100035837 Therapeutic or prophylactic agent for vasoconstriction |